|
1
|
van Uden D, Boomars K and Kool M:
Dendritic cell subsets and effector function in idiopathic and
connective tissue disease-associated pulmonary arterial
hypertension. Front Immunol. 10(11)2019.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Wang HMF: Progress of diagnosis and
treament of connective tissue disease related pulmonary arterial
hypertension. J Med Recapitulate. 18:1686–1689. 2012.
|
|
3
|
Humbert M, Kovacs G, Hoeper MM,
Badagliacca R, Berger RMF, Brida M, Carlsen J, Coats AJS,
Escribano-Subias P, Ferrari P, et al: 2022 ESC/ERS guidelines for
the diagnosis and treatment of pulmonary hypertension. Eur Heart J.
43:3618–3731. 2022.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Cansu DU and Korkmaz C: Pulmonary
hypertension in connective tissue diseases: Epidemiology,
pathogenesis, and treatment. Clin Rheumatol. 42:2601–2610.
2023.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Rhee RL, Gabler NB, Sangani S, Praestgaard
A, Merkel PA and Kawut SM: Comparison of treatment response in
idiopathic and connective tissue disease-associated pulmonary
arterial hypertension. Am J Respir Crit Care Med. 192:1111–1117.
2015.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Mukerjee D, St George D, Coleiro B, Knight
C, Denton CP, Davar J, Black CM and Coghlan JG: Prevalence and
outcome in systemic sclerosis associated pulmonary arterial
hypertension: Application of a registry approach. Ann Rheum Dis.
62:1088–1093. 2003.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Clements PJ, Tan M, McLaughlin VV, Oudiz
RJ, Tapson VF, Channick RN, Rubin LJ and Langer A: Pulmonary
Arterial Hypertension Quality Enhancement Research Initiative
(PAH-QuERI) Investigators. The pulmonary arterial hypertension
quality enhancement research initiative: comparison of patients
with idiopathic PAH to patients with systemic sclerosis-associated
PAH. Ann Rheum Dis. 71:249–252. 2012.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Zhang RF, Zhou L, Ma GF, Shao FC, Wu XH
and Ying KJ: Diagnostic value of transthoracic Doppler
echocardiography in pulmonary hypertension: a meta-analysis. Am J
Hypertens. 23:1261–1264. 2010.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Donato L, Giovanna Elisiana C, Giuseppe G,
Pietro S, Michele C, Brunetti ND, Valentina V, Matteo DB and Maria
Pia FB: Utility of FVC/DLCO ratio to stratify the risk of mortality
in unselected subjects with pulmonary hypertension. Intern Emerg
Med. 12:319–326. 2017.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Sivova N, Launay D, Wémeau-Stervinou L, De
Groote P, Remy-Jardin M, Denis G, Lambert M, Lamblin N,
Morell-Dubois S, Fertin M, et al: Relevance of partitioning DLCO to
detect pulmonary hypertension in systemic sclerosis. PLoS One.
8(e78001)2013.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Hsu VM, Chung L, Hummers LK, Wigley F,
Simms R, Bolster M, Silver R, Fischer A, Hinchcliff ME, Varga J, et
al: Development of pulmonary hypertension in a high-risk population
with systemic sclerosis in the pulmonary hypertension assessment
and recognition of outcomes in scleroderma (PHAROS) cohort study.
Semin Arthritis Rheum. 44:55–62. 2014.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Li Y, Zhang R, Shan H, Shi W, Feng X, Chen
H, Yang X, Li Y, Zhang J and Zhang M: FVC/D(LCO) identifies
pulmonary hypertension and predicts 5-year all-cause mortality in
patients with COPD. Eur J Med Res. 28(174)2023.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Aringer M, Costenbader K, Daikh D, Brinks
R, Mosca M, Ramsey-Goldman R, Smolen JS, Wofsy D, Boumpas DT, Kamen
DL, et al: 2019 european league against rheumatism/American college
of rheumatology classification criteria for systemic lupus
erythematosus. Ann Rheum Dis. 78:1151–1159. 2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Aletaha D, Neogi T, Silman AJ, Funovits J,
Felson DT, Bingham CO 3rd, Birnbaum NS, Burmester GR, Bykerk VP,
Cohen MD, et al: 2010 rheumatoid arthritis classification criteria:
An American college of rheumatology/european league against
rheumatism collaborative initiative. Arthritis Rheum. 62:2569–2581.
2010.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Lundberg IE, Tjärnlund A, Bottai M, Werth
VP, Pilkington C, Visser M, Alfredsson L, Amato AA, Barohn RJ,
Liang MH, et al: 2017 european league against rheumatism/American
college of rheumatology classification criteria for adult and
juvenile idiopathic inflammatory myopathies and their major
subgroups. Ann Rheum Dis. 76:1955–1964. 2017.PubMed/NCBI View Article : Google Scholar
|
|
16
|
van den Hoogen F, Khanna D, Fransen J,
Johnson SR, Baron M, Tyndall A, Matucci-Cerinic M, Naden RP,
Medsger TA Jr, Carreira PE, et al: 2013 classification criteria for
systemic sclerosis: An American college of rheumatology/European
league against rheumatism collaborative initiative. Ann Rheum Dis.
72:1747–1755. 2013.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Shiboski CH, Shiboski SC, Seror R,
Criswell LA, Labetoulle M, Lietman TM, Rasmussen A, Scofield H,
Vitali C, Bowman SJ, et al: 2016 American college of
rheumatology/european league against rheumatism classification
criteria for primary Sjögren's syndrome: A consensus and
data-driven methodology involving three international patient
cohorts. Arthritis Rheumatol. 69:35–45. 2017.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Sharp GC, Irvin WS, Tan EM, Gould RG and
Holman HR: Mixed connective tissue disease-an apparently distinct
rheumatic disease syndrome associated with a specific antibody to
an extractable nuclear antigen (ENA). Am J Med. 52:148–159.
1972.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Wanger J, Clausen JL, Coates A, Pedersen
OF, Brusasco V, Burgos F, Casaburi R, Crapo R, Enright P, van der
Grinten CP, et al: Standardisation of the measurement of lung
volumes. Eur Respir J. 26:511–522. 2005.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Graham BL, Brusasco V, Burgos F, Cooper
BG, Jensen R, Kendrick A, MacIntyre NR, Thompson BR and Wanger J:
2017 ERS/ATS standards for single-breath carbon monoxide uptake in
the lung. Eur Respir J. 49(1600016)2017.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Johnson DC: Importance of adjusting carbon
monoxide diffusing capacity (DLCO) and carbon monoxide transfer
coefficient (KCO) for alveolar volume. Respir Med. 94:28–37.
2000.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Fisher MR, Criner GJ, Fishman AP, Hassoun
PM, Minai OA, Scharf SM and Fessler HE: NETT Research Group.
Estimating pulmonary artery pressures by echocardiography in
patients with emphysema. Eur Respir J. 30:914–921. 2007.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Sarzi-Puttini P, Atzeni F, Gerli R,
Bartoloni E, Doria A, Barskova T, Matucci-Cerinic M, Sitia S,
Tomasoni L and Turiel M: Cardiac involvement in systemic rheumatic
diseases: An update. Autoimmun Rev. 9:849–852. 2010.PubMed/NCBI View Article : Google Scholar
|
|
24
|
McGoon MD and Miller DP: REVEAL: A
contemporary US pulmonary arterial hypertension registry. Eur
Respir Rev. 21:8–18. 2012.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Thakkar V, Stevens WM, Prior D, Moore OA,
Byron J, Liew D, Patterson K, Hissaria P, Roddy J, Zochling J, et
al: N-terminal pro-brain natriuretic peptide in a novel screening
algorithm for pulmonary arterial hypertension in systemic
sclerosis: A case-control study. Arthritis Res Ther.
14(R143)2012.PubMed/NCBI View
Article : Google Scholar
|
|
26
|
Coghlan JG, Denton CP, Grünig E, Bonderman
D, Distler O, Khanna D, Müller-Ladner U, Pope JE, Vonk MC, Doelberg
M, et al: Evidence-based detection of pulmonary arterial
hypertension in systemic sclerosis: The DETECT study. Ann Rheum
Dis. 73:1340–1349. 2014.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Condliffe R, Kiely DG, Peacock AJ, Corris
PA, Gibbs JS, Vrapi F, Das C, Elliot CA, Johnson M, DeSoyza J, et
al: Connective tissue disease-associated pulmonary arterial
hypertension in the modern treatment era. Am J Respir Crit Care
Med. 179:151–157. 2009.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Humbert M, Sitbon O, Chaouat A, Bertocchi
M, Habib G, Gressin V, Yaici A, Weitzenblum E, Cordier JF, Chabot
F, et al: Pulmonary arterial hypertension in France: Results from a
national registry. Am J Respir Crit Care Med. 173:1023–1030.
2006.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Zhao J, Wang Q, Liu Y, Tian Z, Guo X, Wang
H, Lai J, Huang C, Yang X, Li M and Zeng X: Clinical
characteristics and survival of pulmonary arterial hypertension
associated with three major connective tissue diseases: A cohort
study in China. Int J Cardiol. 236:432–437. 2017.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Jeon CH, Chai JY, Seo YI, Jun JB, Koh EM
and Lee SK: pulmonary hypertension study group of Korean College of
Rheumatology. Pulmonary hypertension associated with rheumatic
diseases: Baseline characteristics from the Korean registry. Int J
Rheum Dis. 15:e80–e89. 2012.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Chen HHC: The utilization of right heart
catheterization in the context of pulmonary arterial hypertension.
J Clin Int Med. 39:156–158. 2022.
|
|
32
|
Meyrick B and Reid L: Pulmonary
hypertension. Anatomic and physiologic correlates. Clin Chest Med.
4:199–217. 1983.PubMed/NCBI
|
|
33
|
Sun XG, Hansen JE, Oudiz RJ and Wasserman
K: Pulmonary function in primary pulmonary hypertension. J Am Coll
Cardiol. 41:1028–1035. 2003.PubMed/NCBI View Article : Google Scholar
|
